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DELETERIOUS INTERACTION BETWEEN BMP2 AND TGF-BETA
SIGNALING IN ARTICULAR CHONDROCYTES: HARMFUL ROLE FOR
BMP2 IN OA?
E.N. Blaney Davidson, A.P. van Caam, L. de Kroon, E.L. Vitters,
W.B. van den Berg, P.M. van der Kraan. Radboud Univ. Nijmegen Med.
Ctr., Nijmegen, Netherlands
Purpose: TGF-beta signaling via Smad2/3 is crucial for cartilage main-
tenance. Smad2/3 maintains a healthy chondrocyte phenotype by
inhibiting chondrocyte hypertrophy. We have previously shown that
loss of Smad2/3 signaling is a hallmark of both ageing and OA. BMP2,
a TGF beta family member, signals via Smad1/5/8 instead of Smad2/3.
During OA we found that BMP2 is elevated near lesions. We have
investigated whether BMP2, and as a consequence Smad1/5/8 signaling,
affects Smad2/3 signaling and what are the biological consequences of
this.
Methods: Primary bovine chondrocytes were exposed to BMP2 followed
by Western blotting for Smad2/3P after 60, 180 and 420 minutes. To
study whether the observed effects were reproducible in vivo we
injected Ad-BMP2 i.a. into murine knee joints; Ad-luc was used as
a control. We isolated knee joints after 3 days for immunohistochem-
istry on Smad2/3P.
To address biological relevance of decreased Smad2/3P, human OA
cartilage explants obtained from patients undergoing joint replacement
surgery after informed consent were exposed to the Smad2/3P inhibitor
SB-505124. After 48 hours RNA was isolated to investigate MMP13 levels
as a marker for hypertrophy and OA marker. In addition, we exposed
primary bovine chondrocytes to BMP2 and evaluated whether that had
an effect on MMP13 levels as well.As we observed that BMP2 reduced
Smad2/3P signaling and stimulated MMP13 expression we wanted to
investigate whether this effect could be reversed by extra stimulation of
the Smad2/3 route. Therefore chondrocytes were exposed to a combina-
tion of BMP2 and TGF-beta. Moreover, human OA cartilage explants were
exposed to TGF-beta to investigate whether this reduced MMP13
expression.
Results: Exposing primary bovine chondrocytes to 15 or 50 ng BMP2
led to a decrease in Smad2/3 phosphorylation on Western Blot already
after 60 minutes and that was sustained until at least 420 minutes
compared to non-stimulated controls. We conﬁrmed this effect in vivo
as over expression of BMP2 in murine knee joints led to decreased
Smad2/3P positive cells in both patella and tibia by 55% and 43%
respectively.
To investigate the functional consequence of decreased Smad2/3 signaling
we cultured human OA cartilage explants in the presence of SB-505124.
This led to a signiﬁcant increase in MMP13 expression of 13,6 fold
(p<0.02). A similar increase in MMP13 expression was also observed in
cultures of primary bovine chondrocytes 48 hours after stimulation with
BMP2.
Interestingly, the effect of either 15 or 50 ng BMP2 could be prevented
by addition of TGF-beta, which prevented the decrease in Smad2/3P
levels, but only when a dose of 10 ng/ml TGF-beta was used. A lower
dose of 0.5 ng/ml TGF-beta was insufﬁcient to overcome the BMP2-
induced Smad2/3P decrease. This indicates that TGF-beta can overcome
the BMP2 effect in a dose-dependent manner. Even in human OA
cartilage that had spontaneously reduced Smad2/3P levels addition of
10ng/ml TGF-beta could still decrease MMP13 expression by 6.6 fold
(p<0.005).Conclusions: Our data conﬁrm that BMP2 down regulates Smad2/3
signaling in articular chondrocytes both in vitro and in vivo. A decreased
Smad2/3 signaling in turn results in up regulated levels of MMP13
expression suggesting that BMP2 up regulation, as found adjacent to OA
lesions, is deleterious for articular cartilage. Moreover, we show that this
negative effect of BMP2 can be overcome by addition of TGF-beta, thereby
raising levels of Smad2/3P. Even in human OA cartilage that has naturally
high levels of MMP13 and low levels of Smad2/3P, TGF-beta addition can
still reduce MMP13 expression levels.
Overall our data suggest that BMP2 induces OA-like effects in articular
cartilage, down regulating Smad2/3P and up regulating MMP13, which can
be overcome by enhanced TGF-beta signaling.
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MICRORNA-453 REGULATES IL-1b-INDUCED SONIC HEDGEHOG (SHH)
GENE EXPRESSION IN OSTEOARTHRITIS
N. Akhtar, T.M. Haqqi. MetroHlth. Med. Ctr./CWRU, Cleveland, OH, USA
Background: MicroRNA (miRNAs) are a recently discovered class of
small, (17-25 nt) evolutionarily conserved non-coding RNAs that are
critical post-transcriptional regulators of at least 30% of all human
protein-encoding genes expression. Sonic Hedgehog (SHH) morphogen is
an essential signaling molecule required for numerous processes during
development and has recently been implicated in OA pathogenesis.
However, regulation of SHH expression in OA remains unclear. Here we
studied (a) whether IL-1b-induce the expression of SHH; and (b) whether
miRNAs play a role in regulating the expression of SHH in osteoarthritis
(OA).
Methods: Chondrocytes were derived by enzymatic digestion of human
cartilage (OA chondrocytes) undergoing total knee arthroplasty. Chon-
drocytes were stimulated with IL-1b (5ng/ml) in vitro and total RNA was
prepared. Expression of SHH protein in cartilage was determined by
immunohistochemistry and expression of its downstream targets PTCH-1,
GLI-1, HHIP, ADAMTS-5 and MMP-13 was quantiﬁed by TaqMan Assays.
miRGen Targets was used to identify miRNAs that potentially target the
SHH mRNA and free energy scores of selected miRNA:mRNA hybrids
were determined using RNAHybrid program. miRNAs were puriﬁed
using the mirVANA system and single stranded cDNA was synthesized
with the stem loop primers and the expression of miRNAs was quan-
tiﬁed using TaqMan Assays. Binding of speciﬁc miRNAs to target
sequences was veriﬁed by Luciferase assay. HEK293 cells were co-
transfected with pre-miRNAs and SHH expression plasmid and protein
expression was determined by Western Immunoblotting. Data was
analyzed using Origin 6.1 software package and p<0.05 was considered
signiﬁcant.
Results: Our results showed that the expression of SHH was higher in
damaged cartilage compared to smooth cartilage obtained from OA
patients at the time of knee arthroplasty. The expression of SHH signaling
genes and their downstream targets (PTCH-1, GLI-1 and HHIP, MMP-13,
ADAMTS-5 and COL10A1) was also higher in damaged cartilage. Using
Bioinformatics we identiﬁed several miRNAs including Hsa-miR-453 (miR-
453), Hsa-miR-602 (miR-602) and Hsa-miR-608 (miR-608) with seed
matched sites located within the open reading frame (ORF) of the
human SHH mRNA. IL-1b-stimulation (10ng/ml) of OA chondrocytes
resulted in signiﬁcant up-regulation of SHH mRNA (w11.3-fold at 6h;
w15.5-fold at 12h) and protein expression in OA chondrocytes obtained
from damaged cartilage. In addition, IL-1b-stimulation also down regu-
lated the expression of miR-453 (w4.6-fold at 6h; w11.6-fold at 12h),
miR-602 (w3.9-fold at 6h; w2.9-fold at 12h) and miR-608 (w3.6-fold at
6h; w7.5-fold at 12h) in OA chondrocytes. Co-transfection of OA chon-
drocytes with the Luciferase reporter vector containing only the ORF of
SHH mRNA and miR-453 blocked the luciferase activity. Over expression
of miR-453 in HEK-293 cells (which do not express endogenous miR-453)
transfected with a SHH expression plasmid resulted in signiﬁcant inhi-
bition of SHH mRNA and protein expression while HEK-293 cells with
overexpression of a negative control miRNA showed no inhibition of SHH
expression.
Conclusions: Our ﬁndings demonstrate that miR-453 directly binds
the seed sequence present within the ORF of SHH mRNA. These results
also identify miR-453 as a new potential endogenous regulator of SHH
